Aims and objectives of service. The Pharmacy First Minor Ailments Service is primarily designed as a “walk in” service so that patients exempt from prescription charges of all ages can access self-care advice for the treatment of minor ailments and, where appropriate, be supplied with over the counter medicines, without the requirement to attend their GP practice for an appointment and prescription.
Aims and objectives of service. 1. To improve the mental and emotional health and wellbeing of children with autism, through training and early intervention with parents and professionals.
2. To raise the expectations of parents, carers and professionals who will be working with children with autism and help them to realise the child’s full potential.
3. The programme will help families to: • Understand their child’s autism • Better cope with their autistic child’s behaviour • Structure interactions to enable communication to develop • Develop strategies to pre-empt challenging behaviours and deal with those that might occur • Improve the quality of family life resulting in the prevention of family breakdown
Aims and objectives of service. 1.1 This service aims to improve health outcomes and quality of life amongst Hull residents by identifying individuals at an earlier stage of vascular change, and provide opportunities to empower them to substantially reduce their risk of cardiovascular morbidity or mortality.
Aims and objectives of service. 3.1 To increase access for young people to advice about sexual health and contraceptive services 3.2 To increase access to Chlamydia testing and treatment 3.3 To know how and when to refer young people for more specialist advice, testing and treatment 3.4 To increase access to free pregnancy testing and referral on to abortion, contraception or support services as appropriate 3.5 To increase the number of venues where young people can access free condoms 3.6 To increase the awareness of young people of the incidence and effects of STIs 3.7 To increase the awareness of young people of how they can help reduce their risk of STIs and unplanned pregnancy 3.8 To increase access to Emergency Hormonal Contraception for young women aged 13 -24 years 3.9 To help increase health seeking behaviour among young people aged 13 -24 years.
Aims and objectives of service. In the United Kingdom (UK) up to 40 patients per year become dialysis dependent having under gone renal cancer surgery. Ex-vivo partial nephrectomy and renal auto- transplantation (EPN) is an operation that can be used to treat complex cancers in patients with a single kidney not suitable for other nephron sparing approaches. EPN offers suitable patients the possibility of cancer cure and avoidance of a life on dialysis. The overall aim of the service is to provide patients with complex renal tumours in solitary kidneys or bilateral disease not suitable for conventional treatments, the possibility of cancer cure and avoidance of dialysis. Between 1997 and 2007, approximately 300 patients in the UK developed end stage renal failure requiring renal replacement therapy as a direct consequence of renal cancer surgery (data from the UK renal register). A proportion of these patients may have avoided dialysis had they had the option of an EPN. We anticipate that 50% of the patients with complex T1-2 tumours may be suitable for an EPN. National commissioning of ex- vivo partial nephrectomy now means that up to 20 potentially salvageable patients will be no longer be rendered anephric and dialysis dependent. It is expected that the EPN service will result in significant quality of life and cost benefits to the health service in England.
Aims and objectives of service. The National Insulin Resistant Diabetes Service provides a multidisciplinary outpatient clinic at Cambridge University Hospitals NHS Foundation Trust (CUH) plus inpatient stays for initiation of therapy when indicated. The aim of the service is to provide diagnostic, therapeutic and educational support for both patients and their local clinical carers, and to establish and disseminate evidence-based recommendations for the therapy of this severe group of conditions. The service is targeted at patients with lipodystrophy and/or extreme insulin resistance as defined below (in 2.1). These are very rare but metabolically devastating disorders associated with significant long-term morbidity and mortality. The purpose of the service is to improve outcomes for these patients through the following mechanisms: • by providing a precise diagnosis wherever possible • by the provision of targeted specialist delivered treatment interventions including both dietary and pharmacological therapies • by educating patients, their relatives (where this is appropriate) and local health carers • by raising the profile of severe insulin resistance/lipodystrophy as a clinical problem in order to improve access to optimal care for affected patients. Objectives and expected outcomes Diagnosis Accurate clinical assessment is an essential step to putting the correct management strategies in place early for this group of patients. This requires close links to clinical biochemistry, molecular genetics and radiology services, to provide a complete, integrated package of clinical, biochemical and radiological evaluation as well as definitive molecular genetic diagnosis where appropriate. Objective 1 • To provide a specific diagnosis to all patients with lipodystrophy/severe insulin resistance. This is not currently possible as the genetic basis of several of the disease
Aims and objectives of service. The aim of the lung cancer service is to deliver high quality holistic care for patients with lung cancer so as to increase survival while maximising a patient’s functional capability and quality of life and to ensure ready and timely access to appropriate supportive care for patients, their relatives and carers. The service is delivered through primary care (prevention, recognition, referral and supportive and palliative care), and a local lung cancer multi-disciplinary team (MDT), with specialist providers (diagnosis, treatment, supportive and palliative care). Excellence in outcomes for lung cancer patients is dependent on factors crossing health sector boundaries. These include: A pro-active approach to prevention of lung cancer through smoking cessation. This is a priority for all smoking related diseases but in lung cancer the effect extends to better outcomes throughout the pathway. Primary, secondary and tertiary providers should include smoking cessation advice and referrals in their management of patients with suspected and diagnosed lung cancer. New tobacco control initiatives, as recommended by the Independent Cancer Taskforce should be supported. Awareness of the early symptoms of lung cancer and of the benefits of making the diagnosis early within the general population is vital A high level of awareness and prompt attention to warning symptoms in primary care Access to expert diagnostic and specialist treatment services.
Aims and objectives of service. The aim of the service is to increase access to sexual health services in Kirklees in order to reduce unintended pregnancies and improve sexual health. In addition the services will increase knowledge of the consequences of risky sexual behaviour by providing information and advice as appropriate on sexual health issues including STIs, avoiding unplanned pregnancy, contraception and delaying sex (as appropriate). The service will also improve awareness of the range of sexual health services available in the area. • Specifically, the services will comprise: a consultation, information and advice, signposting to other services, provision of emergency hormonal contraception (EHC), pregnancy testing, Chlamydia screening and provision of condoms. • Females aged 13 and over who present within 120 hours of unprotected sexual intercourse will be provided with emergency hormonal contraception (subject to circumstances) free of charge • The Contract allows the Provider to supply Levonorgestrol or Ulispristal emergency hormonal contraception to appropriate clients in line with relevant guidance and patient group directions, by accredited pharmacists from the accredited Provider. • Increase the Public Health role of the community pharmacist and promote multidisciplinary working in relation to sexual health.
Aims and objectives of service. The aim of the service is to maintain people at home when safe and appropriate to do so and thereby reducing admissions to hospital, reducing inpatient lengths of stay and reducing readmissions. • To adopt a client centred approach in which the individual takes on an active role to achieve maximum independence and quality of life, with the Intermediate Care team supporting the individual to set achievable objectives to help them attain their long term goals. • To provide a zone-led intermediate care service and medical input to enable the client to remain in their own home, wherever possible; where this is not possible in a short-term nursing or residential home placement with regular therapeutic & nursing interventions.
Aims and objectives of service. The aim of the service will be to provide a specialist service for patients with Neuromyelitis Optica (NMO) and NMO spectrum disorders.. The NMO service will offer; a rapid access diagnostic service; patient and clinical advice; supervision of clinical management in collaboration with the local referrer and for severe and acute cases provide in-patient treatment. This multi-disciplinary service will encompass all aspects of diagnosis and treatment recognising the complementary strengths and utilising the specialist clinical and laboratory skills available in conjunction with local services. The diagnostic skills will include imaging, (the atypical and variable appearances will require expert neuroradiology input), NMO antibody testing at the Oxford unit, and histology (which will require expert neuropathology experience). Treatment includes : • advice on immunosuppressive therapy and its monitoring • delivering aggressive therapies in severe cases where local centres lack experience • providing paediatric input for children • physiotherapy input to assess disability and advice on a local rehabilitation programme • maintaining a phone help line. Many neurologists do not have experience or the clinical facilities to supervise aggressive immunosuppression. However early diagnosis and appropriate treatment of NMO will prevent irreversible and severe disability. A UK specialist NMO service aims to reduce mis-diagnoses and inappropriate treatment. The NMO service would thus produce national guidelines for UK neurologists for early referral of potential patients to maximise benefits Additionally, as with all rare conditions, the added value for patient’s lies in being seen by a team of specialists (not only doctors, but specialist nurses, physios etc) who understand their condition and can advise on prognosis and rehabilitation schedules. Concentrating patients with a rare disorder through a specialist service improves the ability to recruit into clinical trials, which are needed to provide evidence for the most effective and cost-effective treatments.
